Kala Azar

 

Kala-Azar (Visceral Leishmaniasis)

Kala-azar, or Visceral Leishmaniasis (VL), is a protozoan infection caused by Leishmania donovani. It is a major target for elimination in the Indian subcontinent.


1. Epidemiology & Transmission

  • Vector: Female Phlebotomus argentipes (Sandfly).
  • Transmission: Bite of an infected female sandfly.
  • Host: Primarily anthroponotic (human-to-human via vector) in the Indian subcontinent.

2. Clinical Features (The “Classic” Presentation)

  • Fever: Often irregular or double-peak (dromedary) fever.
  • Splenomegaly: Typically massive; hepatomegaly is also common.
  • Pancytopenia: Anemia, leukopenia, and thrombocytopenia.
  • Pigmentation: Darkening of the skin (hence “Kala-azar” or “Black Fever”).
  • Weight Loss & Cachexia.

3. Diagnostic & Management Summary

Category Details
Gold Standard Demonstration of amastigotes (LD bodies) in splenic aspirate.
Field Test rK39 strip test (highly sensitive/specific).
Treatment Single-dose Liposomal Amphotericin B (first-line).

4. Post-Kala-Azar Dermal Leishmaniasis (PKDL)

A complication occurring months or years after treatment, presenting with macular, papular, or nodular skin lesions. These patients serve as an important reservoir for infection.


NEET PG Hint: Remember that splenic aspiration is the most sensitive diagnostic test, but it is contraindicated if the platelet count is < 40,000 or if there is a severe bleeding risk. Always prioritize rK39 as the initial diagnostic test in the field. For more high-yield infectious disease topics, visit mymedschool.org.